Medifast, Inc. provided earnings guidance for the fourth quarter and full year of 2026. For the quarter, the company expects fourth quarter 2026 revenue to be in the range of $55 million to ...
“Diet can correct deficiencies and support growth and immunity, which matters because deficiency states do seem to track with disease severity,” says Dr. Shah. But there’s no evidence from clinical ...
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results